Bionano announces 2024 symposium: four consecutive days of ogm presentations and live panel discussions across a wide range of research applications

San diego, jan. 10, 2024 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its 2024 symposium, the quintessential event for the optical genome mapping (ogm) community. the event is an opportunity for ogm users to present their progress to the world. 2024 symposium will feature four consecutive days of ogm presentations delivered by 27 different customers worldwide across a wide range of applications in cancer, cell and gene therapy, and constitutional genetic disease. the symposium will take place virtually from january 22 to 25, 2024. each day will feature user presentations, a live panel with q&a, and scientific posters within the virtual exhibition hall. on day 2, bionano will unveil a new product expected to advance cytogenetics and structural variant analysis.
BNGO Ratings Summary
BNGO Quant Ranking